TTrialPathMatch Me to Trials
← Back to trials
RecruitingMucopolysaccharidosis IH/SMucopolysaccharidosis IS

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Eligible age

10+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A first-in-human study using ISP-001 in patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.

Sponsor: Immusoft of CA, Inc.

You may qualify if…

  • ✓ Diagnosis of Mucopolysaccharidosis type I Hurler-Scheie or Scheie syndrome.
  • ✓ Age ≥ 10 years at time of study registration.
  • ✓ Creatinine clearance, calculated or measured directly, that is \>60ml/min/1.73m2.
  • ✓ Ejection fraction ≥ 40% by echocardiogram.
  • ✓ Must commit to traveling to the study site for the necessary follow-up evaluations.
  • ✓ Must agree to stay \<45-minute drive from the study site for a minimum of 5 days after cell infusion.

You may not qualify if…

  • ✕ Known familial inherited cancer syndrome. Suspected cases will be investigated, per the physicians discretion, using relevant genetic tests to determine presence of germline mutations.
  • ✕ History of B cell related cancer, EBV lymphoproliferative disease or autoimmune disorders.
  • ✕ Evidence of active graft-vs-host disease.
  • ✕ Underwent a previous hematopoietic stem cell transplant (HSCT).
  • ✕ Requirement for systemic immune suppression.
  • ✕ Requirement for continuous supplemental oxygen.
  • ✕ Any medical condition likely to interfere with assessment of safety or efficacy of the study treatment.
  • ✕ In the investigator's judgement, the subject is unlikely to complete all protocol-required study visits or procedures, including follow up visits, or comply with the study requirements for participation.

Where it's recruiting

California

Oakland

Minnesota

Minneapolis

Source: ClinicalTrials.gov · NCT05682144 · last updated 2026-07-17